Irhythm Technologies, INC Form 4 insider transactions

iRhythm Holdings' Chief Accounting Officer, Marc Rosenbaum, sold shares of common stock to cover tax obligations related to RSU vesting.

iRhythm Holdings, Inc.'s Chief Financial Officer, Daniel G. Wilson, sold 3,395 shares of common stock to cover tax withholding obligations related to RSU vesting.

iRhythm Holdings President and CEO, Quentin S. Blackford, sold common stock totaling 13,813 shares to cover tax obligations related to RSU vesting.

iRhythm Holdings, Inc. Chief Financial Officer Daniel G. Wilson acquired 8,361 Restricted Stock Units, vesting over four years.

iRhythm Holdings, Inc. Chief Medical/Scientific Officer Minang Turakhia was granted 10,034 Restricted Stock Units.

iRhythm Holdings, Inc. President and CEO, Quentin S. Blackford, was granted 31,842 Restricted Stock Units, vesting over four years.

iRhythm Holdings' Chief Communications & Product Officer, Chad Patterson, received a grant of 10,870 Restricted Stock Units.

iRhythm Holdings, Inc. Chief Accounting Officer Marc Rosenbaum was granted 2,508 Restricted Stock Units, vesting over four years.

iRhythm Holdings, Inc. reports a future grant of 7,024 Restricted Stock Units to Patrick Michael Murphy, Chief Business Officer and Chief Legal Officer, vesting over four years.

iRhythm Holdings' EVP of Strategic Business Operations, Mervin Smith, acquired 6,689 Restricted Stock Units, increasing his beneficial ownership to 26,964 shares.

iRhythm Holdings' EVP of Strategy & Corporate Development, Sean Clinton Freeman, acquired 7,525 restricted stock units.

iRhythm Holdings, Inc.'s EVP and Chief Risk Officer, Sumi Shrishrimal, was granted 5,518 Restricted Stock Units, vesting over four years.

iRhythm Holdings, Inc.'s Chief Technology Officer, Lawrence Brian Lee, was granted 6,689 Restricted Stock Units following a holding company reorganization.

iRhythm Holdings, Inc.'s Chief Financial Officer, Daniel G. Wilson, reported the acquisition of shares from vested performance RSUs and a subsequent sale to cover tax obligations.

iRhythm Holdings' Chief Medical/Scientific Officer, Minang Turakhia, increased beneficial ownership of common stock following the vesting of performance-based Restricted Stock Units, partially offset by tax-related sales.

iRhythm Holdings' EVP of Strategic Business Operations, Mervin Smith, reported the vesting of performance-based restricted stock units and a subsequent sale of shares to cover tax obligations.

iRhythm Holdings' EVP, Chief Risk Officer, Sumi Shrishrimal, reported the vesting of performance-based restricted stock units and a subsequent sale of shares to cover tax obligations.

iRhythm Holdings' Chief Accounting Officer, Marc Rosenbaum, acquired 9,210 shares from RSU vesting and subsequently sold 4,797 shares for tax obligations.

iRhythm Holdings' Chief Communications & Product Officer, Chad Patterson, reported the vesting of performance-based restricted stock units and a subsequent sale of shares to cover tax obligations.

iRhythm Holdings' Chief Business and Legal Officer, Patrick Michael Murphy, reported the acquisition of shares from RSU vesting and subsequent sale to cover tax obligations.

iRhythm Holdings' President and CEO, Quentin S. Blackford, acquired shares from RSU vesting and subsequently sold a portion to cover tax obligations.

iRhythm Holdings, Inc.'s Chief Accounting Officer, Marc Wade Rosenbaum, sold 280 shares of common stock for $140.91 per share as part of a pre-arranged trading plan.

iRhythm Holdings, Inc. EVP Mervin Smith sold 732 shares of common stock for $140.91 per share as part of a pre-arranged trading plan.

iRhythm Holdings Director Abhijit Y. Talwalkar exercised stock options and sold 5,312 shares of common stock on February 23, 2026, as part of a pre-arranged trading plan.

iRhythm Technologies' Chief Communications & Product Officer, Chad Patterson, sold 280 shares of common stock for $184.83 per share under a pre-arranged 10b5-1 plan.

iRhythm Technologies' CBO and CLO, Patrick Michael Murphy, sold 2,478 shares of common stock at $184.83 per share to cover tax obligations related to Restricted Stock Unit vesting.

iRhythm Technologies' Chief Medical/Scientific Officer, Minang Turakhia, acquired 250 shares of common stock through the company's Employee Stock Purchase Plan.

iRhythm Technologies' EVP, Chief Risk Officer Sumi Shrishrimal, acquired 73 shares of common stock through the company's Employee Stock Purchase Plan.

iRhythm Technologies' Chief Accounting Officer, Marc Rosenbaum, acquired 2 shares of common stock through the company's Employee Stock Purchase Plan.

iRhythm Technologies Director Abhijit Y. Talwalkar exercised stock options and subsequently sold an equal number of common shares under a pre-arranged 10b5-1 trading plan.